Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
SION

Updated 10/6/2026, 10:27 AM ET.

SION

Sionna Therapeutics, Inc.

Sale$21,835,018

RA CAPITAL MANAGEMENT, L.P.

Director, 10% owner

and 5 others

3,448,811 shat $6.33Filed Sep 21, 6:56 PM ETFiling
SION

Sionna Therapeutics, Inc.

Sale$3,854,281

Thompson Peter A.

Director

85,918 shat $44.86Filed Jul 9, 4:47 PM ET
Filing
SION

Sionna Therapeutics, Inc.

Sale$3,854,281

ORBIMED ADVISORS LLC

Director

and 1 other

85,918 shat $44.86Filed Jul 9, 4:44 PM ET
Filing

Read from public SEC filings. Not financial advice.